Association Of PTPN22 Gene Polymorphisms in Patients with Graves’ Disease in Iranian Papulation
PTPN22 gene polymorphisms in GD
Abstract
Background: Graves’ disease(GD) is an autoimmune disease that is associated with increased thyroid gland irritation and, consequently, hyperthyroidism. Autoimmune diseases are common in general population which is influenced by both genetic and environmental factors. PTPN22 that was reported as a susceptible locus for GD in several populations, acts as a negative regulator for activation of primary T-cells, and LYP polymorphism could potentially increase susceptibility to Graves' disease which may play a role in other autoimmune conditions as well. In this study we investigated the association of several PTPN22 single nucleotide polymorphisms (SNPs) with Graves patients.
Methods: After DNA extraction from peripheral blood cells, SNP Genotyping was performed through real-time PCR with allelic discrimination TaqMan genotyping assays (ABI Applied Biosystems, 7300 Real-Time PCR System, USA) based on manufacturer protocols. The frequencies of alleles and genotypes of PTPN22 SNPs (rs12760457, rs2476601, rs1310182 and rs1217414) were recorded.
Results: In our study, the rs1310182 was found to be significantly more frequent in patients with GD compared to healthy individuals. While the C allele of rs1310182 was 1.78 times more frequent in GD patients (95%CI: 1.18-2.69, P=0.005), the T allele was more frequent in healthy subjects (OR=0.56, 95% CI: 0.37-0.84, P=0.005). In addition, the CC genotype of this SNP was 1.86 times more common in patients (P=0.05). No significant differences were observed between the other SNPs of this gene in case and control.
Conclusion: The results demonstrate that one SNP (rs1310182) of the PTPN22 gene is associated with susceptibility to GD in an Iranian population. Further studies including functional analyses are required.
2. Li‐qun G, Wei Z, Shuang‐xia Z, Lin Z, Min‐jia Z, Bin C, et al. Clinical associations of the genetic variants of CTLA‐4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves’ disease. Clin endocrinol. 2010;72(2):248-55.
3. Velaga M, Wilson V, Jennings C, Owen C, Herington S, Donaldson P, et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J Clin Endocrinol Metab. 2004;89(11):5862-65.
4. Xue L, Pan C, Gu Z, Zhao S, Han B, Liu W, et al. Genetic heterogeneity of susceptibility gene in different ethnic populations: refining association study of PTPN22 for Graves’ disease in a Chinese Han population. PloS one. 2013;8(12):e84514.
5. Huang J, Yao T, See L. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol. 2004;22(6):776-80.
6. Martini A, Lovell DJ. Juvenile idiopathic arthritis: state of the art and future perspectives. Ann Rheum Dis. 2010;69(7):1260-3.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156-9.
8. Song RH, Qin Q, Yan N, Muhali FS, Meng S, He ST, et al. Variants in IRAK1-MECP2 region confer susceptibility to autoimmune thyroid diseases. Mol Cell Endocrinol. 2015;399:244-9.
9. Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum. 2007;56(12):3989-94.
10. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat genet. 2004;36(4):337.
11. Jia X, Hu M, Lin Q, Ren H. Association of the IRF5 rs2004640 polymorphism with rheumatoid arthritis: a meta-analysis. Rheumatol Int. 2013;33(11):2757-61.
12. Xue L, Pan C, Gu Z, Zhao S, Han B, Liu W, et al. Genetic heterogeneity of susceptibility gene in different ethnic populations: refining association study of PTPN22 for Graves’ disease in a Chinese Han population. PloS one. 2013;8(12).
13. Wawrusiewicz‐Kurylonek N, Koper‐Lenkiewicz OM, Gościk J, Myśliwiec J, Pawłowski P, Krętowski AJ. Association of PTPN 22 polymorphism and its correlation with Graves' disease susceptibility in Polish adult population—A preliminary study. Mol Genet Genomic Med. 2019;7(6):e661.
14. Wang Y, Cui Y, Zhang D, Chen C, Hou C, Cao L. Moderating Role of TSHR and PTPN22 Gene Polymorphisms in Effects of Excessive Fluoride on Thyroid: a School-Based Cross-Sectional Study. Biol Trace Elem Res. 2022;200(3):1104-16.
15. Luo L, Cai B, Liu F, Hu X, Wang L. Association of Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) C1858T gene polymorphism with susceptibility to autoimmune thyroid diseases: a meta-analysis. Endocr J. 2012;59(5):439-45.
16. Skorka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf). 2005;62(6):679-82.
17. Sadr M, Khalili N, Mohebbi B, Mosharmovahed B, Afradi P, Rezaei N. Association of PTPN22 single nucleotide polymorphisms with chronic spontaneous urticaria. Allergol Immunopathol (Madr). 2021;49(2):40-45.
18. Sadr M, Moazzami B, Soleimanifar N, Elhamian N, Rezaei A, Ebrahimi Daryani N, et al. Single Nucleotide Polymorphisms of PTPN22 Gene in Iranian Patients with Ulcerative Colitis. Fetal Pediatr Pathol. 2019;38(1):8-13.
Files | ||
Issue | Vol 5, No 1 (2022) | |
Section | Original Article | |
DOI | https://doi.org/10.18502/igj.v5i1.14068 | |
Keywords | ||
Autoimmune Disease Graves’ Disease PTPN22 Gene Polymorphisms |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |